3D magnetic field guided sunflower-like nanocatalytic active swarm targeting patients-derived organoids

Nanocatalytic medicine triggering in situ catalytic reactions has been considered as a promising strategy for tumor-selective therapeutics. However, the targeted distribution of nanocatalysts was still low, considering the absence of targeting propulsion capability. Here, encouraged by the fast-developing controllable microrobotics for targeting delivery, a sunflower-like nanocatalytic active swarm (SNCAS) controlled by a three-dimensional (3D) magnetic field was proposed for synergistic tumor-selective and magnetic-actively tumor-targeting therapeutics. Furthermore, a patient-derived renal cancer cell 3D organoid was utilized for the verification of the effective tumor therapeutic outcomes. Under the targeted control of 3D magnetic field, the multiple cascade catalytic efficiency of SNCAS based on Fenton reaction was evaluated, resulting in efficient tumor cell apoptosis and death. For the patient-derived organoid treatment, the SNCAS presented significant lethality toward 3D organoid structure to induce cell apoptosis with the collapse of organoid morphology. The targeting efficiency was further enhanced under the magnetic-controllable of SNCAS. Overall, empowered by the magnetic control technology, the synergistic therapeutic strategy based on controllable swarm combined active targeting and tumor-specific catalytic nanomedicine has provided a novel way for advanced cancer therapy. Meanwhile, 3D patient-derived organoids were proved as a powerful tool for the effectiveness verification of nanocatalytic medicine.

Automated summary

Nanocatalytic medicine triggering in situ catalytic reactions has shown promise for tumor-selective therapeutics. However, the distribution of nanocatalysts remains low due to the lack of targeting propulsion capability. In this study, a sunflower-like nanocatalytic active swarm controlled by a 3D magnetic field was proposed for tumor-targeting therapeutics. The efficacy of the swarm was evaluated using a patient-derived renal cancer cell 3D organoid, resulting in efficient tumor cell apoptosis and death. The study highlights the importance of magnetic control technology in advancing cancer therapy and demonstrates the effectiveness of 3D patient-derived organoids for verifying nanocatalytic medicine.